Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-06-20
Original market date: See footnote 1
2009-11-02
Product name:
ESTROPLAN
DIN:
02298406
Product Monograph/Veterinary Labelling:
Date:
2023-06-12
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PARNELL TECHNOLOGIES PTY LTD
4/476 Gardners Road
Alexandria
New South Wales
Australia
2015
Class:
Veterinary
Species:
Cattle
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0112396003
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CLOPROSTENOL (CLOPROSTENOL SODIUM) | 250 MCG / ML |